Team:Freiburg bioware

From 2009.igem.org

(Difference between revisions)
 
(12 intermediate revisions not shown)
Line 86: Line 86:
  class="l"></span><span class="r"></span><span
  class="l"></span><span class="r"></span><span
  class="t">Modeling</span></a></li>
  class="t">Modeling</span></a></li>
 +
<li><a
 +
href="https://2009.igem.org/Team:Freiburg_bioware/general"><span
 +
class="l"></span><span class="r"></span><span
 +
class="t">General Activities</span></a></li>
</ul>
</ul>
</div>
</div>
Line 139: Line 143:
<div class="art-Post-inner">
<div class="art-Post-inner">
<div class="art-PostMetadataHeader">
<div class="art-PostMetadataHeader">
 +
<img src="https://static.igem.org/mediawiki/2009/b/be/Freiburg09_Picture2.png" style="width: 100%">
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"> <span
<h2 style="border-bottom: none;" class="art-PostHeaderIcon-wrapper"> <span
  class="art-PostHeader">Project Summary</span> </h2>
  class="art-PostHeader">Project Summary</span> </h2>
</div>
</div>
<div class="art-PostContent"><span
<div class="art-PostContent"><span
-
  class="art-button-wrapper"></span><b><br />
+
  class="art-button-wrapper"></span><b><table style="text-align: left;"
-
Universal Endonuclease &ndash; Cutting Edge Technology</b>
+
border="0" cellpadding="0" cellspacing="0">
-
<div class="art-PostContent">
+
  <table style="text-align: left;" border="0"
-
<p>Gene technology is driven by the use of restriction
+
cellpadding="2" cellspacing="0">
 +
  <tbody bgcolor="#e2eff9">
 +
    <tr>
 +
      <td><b>Universal Endonuclease &ndash; Cutting
 +
Edge Technology</b>
 +
      <div class="art-PostContent">
 +
      <p>Gene technology is driven by the use of restriction
endonucleases.
endonucleases.
Yet, constraints of limited sequence length and variation recognized by
Yet, constraints of limited sequence length and variation recognized by
Line 162: Line 173:
vivo applications by external adapter delivery, activity regulation by
vivo applications by external adapter delivery, activity regulation by
photo-switching, as well as for modifying an argonaute protein towards
photo-switching, as well as for modifying an argonaute protein towards
-
a DNA endonuclease.
+
a DNA endonuclease.&nbsp;</p>
-
</p>
+
      <p><a
-
</div>
+
href="https://2009.igem.org/Team:Freiburg_bioware/Project">You
 +
can find the Highlights of our projects here</a></p>
 +
      </div>
 +
      </td>
 +
      <td><img alt=""
 +
src="https://static.igem.org/mediawiki/2009/f/fd/Freiburg09_animation90.gif"></td>
 +
      <td><img style="width: 111px; height: 283px;"
 +
alt=""
 +
src="https://static.igem.org/mediawiki/2009/0/00/Freiburg09_Fok_Winner_FluoMikroskop_only.jpg"></td>
 +
    </tr>
 +
  </tbody>
 +
</table>
 +
 
 +
 
 +
<br />
 +
 
<p></p>
<p></p>
</div>
</div>
Line 189: Line 215:
<div class="art-PostContent"><span
<div class="art-PostContent"><span
  class="art-button-wrapper"></span><b><br />
  class="art-button-wrapper"></span><b><br />
-
<img style="width: 730px; height: 300px;" alt="Sponsors"
+
<img alt="Sponsors"
-
  src="https://static.igem.org/mediawiki/2009/b/b8/Freiburg09_Sponsors.png" /><br />
+
  src="https://static.igem.org/mediawiki/2009/c/c8/Freiburg09_Sponsorsneu.jpg" /><br />
</b>
</b>
<p></p>
<p></p>

Latest revision as of 14:00, 24 November 2009

Artisteer

Team Freiburg Bioware


With three years of experience in iGEM and after last year's second place the iGEM Team Freiburg is highly motivated  to deliver some good piece of synthetic biology in 2009. In this year we want to create an universal restriction enzyme to facilitate labwork and enable new techniques.

We're looking forward to meeting you on this year's jamboree!


Universal Endonuclease – Cutting Edge Technology

Gene technology is driven by the use of restriction endonucleases. Yet, constraints of limited sequence length and variation recognized by available restriction enzymes pose a major roadblock for synthetic biology. We developed the basis for universal restriction enzymes, primarily for routine cloning but also with potential for in vivo applications. We use a nucleotide cleavage domain fused to a binding domain, which recognizes a programmable adapter that mediates binding to DNA and thus cleavage. As adapter we use readily available modified oligonucleotides, as binding domain anticalins and as cleavage domain FokI moieties engineered for heterodimerization and activity. For cloning, this universal enzyme has merely to be mixed with the sequence specific oligonucleotide and the target DNA. Binding and release are addressed with thermocycling. Additionally, we provide concepts for in vivo applications by external adapter delivery, activity regulation by photo-switching, as well as for modifying an argonaute protein towards a DNA endonuclease. 

You can find the Highlights of our projects here



Sponsors

FREiGEM 2009

Team
The Team
In 2009 our team consists of  14 undergraduates and 4 advisors.
Read more...

bioss
Bioss

We want to thank our main sponsor Bioss for supporting our project.
Read more...

Visitors